Hong Kong debates reproductive technology bill:
This article was originally published in Clinica
Hong Kong's Legislative Council debated a reproductive technology bill for the first time last week, which aims to prevent embryo gender selection on non-medical grounds. If passed, the Human Reproductive Technology Bill would also impose stringent controls on artificial fertilisation, reports the South China Morning Post. The bill provides for the setting up of a statutory body to oversee establishments engaged in embryo research.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.